Copay Cards

*Eligible patients pay as little as $10

Terms and Conditions apply

Download Copay Cards
* Eligibility required. Individual savings limited to $970 per tube or $3,880 in maximum total savings per calendar year. Only for use with commercial insurance. If you are enrolled in a state or federally funded prescription insurance program, you may not use the savings card.

Order Samples

Register or sign in to check availability and request samples.

Order now

Savings & Support Program

A savings and support program for your patients to help them with their access to EUCRISA

Learn more

“Sometimes I don’t even want to look at my own skin”

Nana is a dancer who has had mild-to-moderate atopic dermatitis for more than 30 years

View Nana's story

Efficacy

EUCRISA has proven efficacy across all primary and secondary endpoints1,2

See more

Safety Data

Learn more about the safety data of EUCRISA from the 4-week pivotal trials and open-label safety extension study1,3

See more

Dosing

EUCRISA can be applied to the skin anywhere on the face and body1
For topical use only. Not for ophthalmic, oral or intravaginal use

See more

References

  1. EUCRISA® (crisaborole) Full Prescribing Information. December 2018.
  2. Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494-503.e4.
  3. Data on File. Pfizer Inc., New York, NY.